Implementation of the 21-Gene Risk Score Assay, OncotypeDx Breast, Within the VASeptember 23, 2015Breast Cancer
The Evaluation of Venous Thromboembolism/Adverse Drug Events in VA Loma Linda Oncology Patients on Warfarin vs Low Molecular Weight HeparinSeptember 23, 2015Oncology
Natalizumab-Associated Melanoma: A Report of 139 Cases From the Southern Network on Adverse Reactions (SONAR)September 23, 2015Melanoma
Did the FDA Black Box Warning Have Any Effect on Erythropoiesis-Stimulating Agent Use?September 23, 2015Oncology
Patterns in the Use of Neoadjuvant and Adjuvant Therapy in Stage II/III Rectal Cancer and Associated SurvivalSeptember 23, 2015Colon and Rectal
Stage IV Rectal Cancer Trends by Year: A Review of the National Cancer Database, 1998 to 2009September 23, 2015Colon and Rectal
Pilot Study: Is In-Network Care for Veterans Diagnosed With Malignant Pleural Mesothelioma (MPM) Feasible With VAHCS?September 23, 2015Lung Cancer
Comparison of Initial Diagnosis and Treatment for Hepatocellular Carcinoma Between VA and Nonveteran PopulationsSeptember 23, 2015Oncology
A Retrospective Evaluation of Outcomes in Veteran Patients With Agent Orange Exposure and Prostate CancerSeptember 23, 2015Oncology
The Efficacy of Abiraterone Pre-and Postdocetaxel and Sequential Use of Enzalutamide After Abiraterone in Veteran Patients With Metastatic Castration-Resistant Prostate CarcinomaSeptember 23, 2015Oncology
Discrepancy in Histologic Subtypes of Non-Small Cell Lung Cancer Between Veterans and the General PopulationSeptember 23, 2015Lung Cancer
Epidemiology of Stage IV Thyroid Cancer Patients: A Review of the National Cancer Database, 2000-2012September 23, 2015Head & Neck/Thyroid Cancers
